Changes in anti-Müllerian hormone serum concentrations over time suggest delayed ovarian ageing in normogonadotrophic anovulatory infertility

Human Reproduction

Volumn 19, Issue 9, 2004, Pages 2036-2042

  Mulders, Annemarie G M G J ^a   Laven, Joop S E ^a   Eijkemans, Marinus J C ^a   de Jong, Frank H ^a   Themmen, Axel P N ^a   Fauser, Bart C J M ^a,b  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Anovulation; Anti M llerian hormone (AMH); Infertility; Ovarian ageing; PCOS

Indexed keywords

GONADOTROPIN; MUELLERIAN INHIBITING FACTOR;

ADOLESCENT; ADULT; AGING; ANOVULATION; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; FEMALE INFERTILITY; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; OVARY FOLLICLE; OVARY FUNCTION; OVARY POLYCYSTIC DISEASE; PREMENOPAUSE; REGRESSION ANALYSIS; TIME;

EID: 4544244654     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/deh373     Document Type: Article

References (50)

1. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP and Grootegoed JA (1995) Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136,4951-4962.
2. Balen AH, Laven JS, Tan SL and Dewailly D (2003) Ultrasound assessment of the polycystic ovary: international consensus definitions. Hum Reprod Update 9,505-514.
3. Beckers NG, Macklon NS, Eijkemans MJ and Fauser BC (2002) Women with regular menstrual cycles and a poor response to ovarian hyperstimulation for in vitro fertilization exhibit follicular phase characteristics suggestive of ovarian aging. Fertil Steril 78,291-297.
4. Bili H, Laven J, Imani B, Eijkemans MJ and Fauser BC (MM) Age-related differences in features associated with polycystic ovary syndrome in normogonadotrophic oligo-amenorrhoeic infertile women of reproductive years. Eur J Endocrinol 145,749-755.
5. Cate RL, Mattaliano RJ, Hession C, Tizard R, Farber NM, Cheung A, Ninfa EG, Frey AZ, Gash DJ, Chow EP et al. (1986) Isolation of the bovine and human genes for Mullerian inhibiting substance and expression of the human gene in animal cells. Cell,45685-45698.
6. Cook CL, Siow Y, Brenner AG and Fallat ME (2002) Relationship between serum mullerian-inhibiting substance and other reproductive hormones in untreated women with polycystic ovary syndrome and normal women. Fertil Steril 77,141-146.
7. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Oden A, Janson PO, Mattson LA, Crona N and Lundberg PA (1992) Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57, 505-513.
8. de Vet A, Laven JS, de Jong FH, Themmen AP and Fauser BC (2002) Anti-mullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77,357-362.
9. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA and Themmen AP (1999) Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140,5789-5796.
10. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, et al. (2001) Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142,4891-4899.
11. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA and Themmen AP (2002) Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143,1076-1084.
12. Elting MW, Korsen TJ, Rekers-Mombarg LT and Schoemaker J (2000) Women with polycystic ovary syndrome gain regular menstrual cycles when ageing. Hum Reprod 15,24-28.
13. Elting MW, Kwee J, Korsen TJ, Rekers-Mombarg LT and Schoemaker J (2003) Aging women with polycystic ovary syndrome who achieve regular menstrual cycles have a smaller follicle cohort than those who continue to have irregular cycles. Fertil Steril 79,1154-1160.
14. ESHRE Capri Workshop Group (1995) Anovulatory infertility. Hum Reprod 10,1549-1553.
15. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ and Nelson JF (1992) Accelerated disappearance of ovarian follicles in mid-life: implications for forecasting menopause. Hum Reprod 7,1342-1346.
16. Fanchin R, Schonauer LM, Righini C, Guibourdenche J, Frydman R and Taieb J (2003a) Serum anti-Mullerian hormone is more strongly related to ovarian follicular status than serum inhibin B, estradiol, FSH, LH on day 3. Hum Reprod 18,323-327.
17. Fanchin R, Schonauer LM, Righini C, Frydman N, Frydman R and Taieb J (2003b) Serum anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation. Hum Reprod 18,328-332.
18. Fauser BC and Van Heusden AM (1997) Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 18,71-106.
19. Hohmann FP, Laven JS, de Jong FH, Eijkemans MJ and Fauser BC (2001) Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development. Hum Reprod 16,846-854.
20. Hughesdon PE (1982) Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called 'hyperthecosis'. Obstet Gynecol Surv 37, 59-77.
21. Imani B, Eijkemans MJ, te Velde ER, Habbema JD and Fauser BC (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83,2361-2365.
22. Imani B, Eijkemans MJ, te Velde E, Habbema JD and Fauser BC (1999) Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84,1617-1622.
23. Josso N, Cate RL, Picard JY, Vigier B, di Clemente N, Wilson C, Imbeaud S, Pepinsky RB, Guerrier D, Boussin L et al. (1993) Anti-mullerian hormone: the Jost factor. Recent Prog Horm Res 48,1-59.
24. Jost A (1947) Recherches sur la differenciation sexuelle de l'embryon de lapin. Arch Anat Microsc Morphol Exp 36,271-315.
25. Kok HV, van Asselt KM, van der Schouw YT, Grobbee DE, te Velde ER, Pearson PL and Peeters PH (2003) Subtertility reflects accelerated ovarian ageing. Hum Reprod 18,644-648.
26. Laven JS, Imani B, Eijkemans MJ and Fauser BC (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57,755-767.
27. Laven JS, Mulders AG, Visser JA, Themmen AP, de Jong FH and Fauser BC (2004) Anti-Mullerian hormone (AMH) serum concentrations in normo-ovulatory and anovulatory women. J Clin Endocrinol Metab 89,318-323.
28. Lee MM and Donahoe PK (1993) Mullerian inhibiting substance: a gonadal hormone with multiple functions. Endocr Rev 14,152-164.
29. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D and MacLaughlin DT (1996) Mullerian inhibiting substance in humaps: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81,571-576.
30. Long WQ, Ranchin V, Pautier P, Belville C, Denizot P, Cailla H, Lhomme C, Picard JY, Bidart JM and Rey R (2000) Detection of minimal levels of serum anti-Mullerian hormone during follow-up of patients with ovarian granulosa cell tumor by means of a highly sensitive enzyme-linked immunosorbent assay. J Clin Endocrinol Metab 85,540-544.
31. Mulders AG, Eijkemans MJ, Imani B and Fauser BC (2003a) Prediction of chances for success or complications in gonadotrophin ovulation induction in normogonadotrophic anovulatory infertility. Reprod Biomed Online 7,170-178.
32. Mulders AG, Laven JS, Imani B, Eijkemans MJ and Fauser BC (2003b) IVF outcome in anovulatory infertility (WHO group 2) - including polycystic ovary syndrome - following previous unsuccessful ovulation induction. Reprod Biomed Online 7,50-58.
33. Nikolaou D and Templeton A (2003) Early ovarian ageing: a hypothesis: detection and clinical relevance. Hum Reprod 18,1137-1139.
34. Pache TD, Hop WC, de Jong FH, Leerentveld RA, van Geldorp H, Van de Kamp TM, Gooren LJ and Fauser BC (1992a) 17 beta-oestradiol, androstenedione and inhibin levels in fluid from individual follicles of normal and polycystic ovaries, and in ovaries from androgen treated female to male transsexuals. Clin Endocrinol 36,565-571.
35. Pache TD, Wladimiroff JW, Hop WC and Fauser BC (1992b) How to discriminate between normal and polycystic ovaries: transvaginal US study. Radiology 183,421-423.
36. Pigny P, Merlen E, Robert Y, Cortet-Rudelli C, Decanter C, Jonard S and Dewailly D (2003) Elevated serum level of anti-mullerian hormone in patients with polycystic ovary syndrome: relationship to the ovarian follicle excess and to the follicular arrest. J Clin Endocrinol Metab 88, 5957-5962.
37. Rajpert-De Meyts E, Jorgensen N, Graem N, Muller J, Cate RL and Skakkebaek NE (1999) Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84,3836-3844.
38. Richardson SJ, Senikas V and Nelson JF (1987) Follicular depletion during the menopausal transition: evidence for accelerated loss and ultimate exhaustion. J Clin Endocrinol Metab 65,1231-1237.
39. Rotterdam ESHRE/ASRM-sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19, 41-47.
40. Rowe PJ, Comhaire FH, Hargreave TB and Mellows H (2000) Female partner. In Rowe PJ, Comhaire FH, Hargreave TB, and Mellows H (eds), WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Press Syndicate of the University of Cambridge, Cambridge, pp. 40-67.
41. Schipper I, de Jong FH and Fauser BC (1998) Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years. Hum Reprod 13,1442-1448.
42. Seifer DB, MacLaughlin DT, Christian BP, Feng B and Shelden RM (2002) Early follicular serum mullerian-inhibiting substance levels are associated with ovarian response during assisted reproductive technology cycles. Fertil Steril 77,468-471.
43. te Velde ER and Pearson PL (2002) The variability of female reproductive ageing. Hum Reprod Update 8,141-154.
44. te Velde ER, Scheffer GJ, Dorland M, Broekmans FJ and Fauser BC (1998) Developmental and endocrine aspects of normal ovarian aging. Mol Cell Endocrinol 145,67-73.
45. van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, de Jong FH and Themmen AP (2002) Serum anti-Mullerian hormone levels: a novel measure of ovarian reserve. Hum Reprod 17,3065-3071.
46. van Santbrink EJ, Hop WC, van Dessel TJ, de Jong FH and Fauser BC (1995) Decremental follicle-stimulating hormone and dominant follicle development during the normal menstrual cycle. Fertil Steril 64,37-43.
47. van Santbrink EJ, Hop WC and Fauser BC (1997) Classification of normogonadotropic infertility: polycystic ovaries diagnosed by ultrasound versus endocrine characteristics of polycystic ovary syndrome. Fertil Steril 67, 452-458.
48. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K and Franks S (2003) Formation and early development of follicles in the polycystic ovary. Lancet 362,1017-1021.
49. Weenen C, Laven JS, von Bergh AR, Cranfield M, Groome NP, Visser J, Kramer P, Fauser BC and Themmen AP (2004) Anti-Mullerian hormone (AMH) expression pattern in the human ovary: potential implications for initial and cyclic recruitment. Mol Hum Reprod 10,77-83.
50. Wise PM, Krajnak KM and Kashon ML (1996) Menopause: the aging of multiple pacemakers. Science 273,67-70.